Childhood acute myeloid leukemia linked to UBTF gene duplications

UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia

NIH-funded research St. Jude Children's Research Hospital · NIH-11162534

This project looks at a specific UBTF gene change in children with acute myeloid leukemia to understand why their disease returns and resists treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital NIH-funded
Lab location1 site (Memphis, United States)
Project IDNIH-11162534 on NIH RePORTER

What this research studies

This project focuses on a gene change called a UBTF exon 13 tandem duplication found in a subset of children with AML. Researchers will analyze tumor samples and clinical records from children with newly diagnosed and relapsed AML to determine how often UBTF-TD occurs and how it relates to outcomes. In the lab they will study patient-derived cells and molecular interactions to see how UBTF-TD changes blood cell growth and connects to other leukemia-related proteins. The team plans to link these biological findings to clinical risk so this group of patients can be better classified and considered for targeted approaches.

Who could benefit from this research

Good fit: Children with acute myeloid leukemia, particularly those with relapsed disease or whose tumor testing shows UBTF exon 13 tandem duplication or associated mutations like FLT3-ITD or WT1, are the most relevant candidates.

Not a fit: Adults without UBTF-TD and patients whose leukemia lacks UBTF-TD are unlikely to get direct benefit from this specific project.

Why it matters

Potential benefit: If successful, this work could help identify children at higher risk of relapse and point to new, more targeted treatment options.

How similar studies have performed: The investigators previously discovered UBTF-TD in pediatric AML and showed it can drive leukemia in laboratory models, but translating this into clinical therapies is still early and novel.

Where this research is happening

Memphis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.